Skip to Main Content

Paper Details

The genetic risk of second cancers: should the therapy for acute lymphoblastic leukemia be individualized according to germline genetic makeup?
Expert Rev Precis Med Drug Dev
2
2018
Author NameAffiliation
Christopher C PorterEmory University School of Medicine
  • 1 - 1

Datasets

Release 1.2